NIH researchers identified potential new antiviral drug for COVID-19
On Jun. 3, 2021, the National Institutes of Health (NIH) announced that the experimental drug TEMPOL may be…
-
-
Innovation Pharma completed enrollment in phase 2 clinical trial for COVID-19
On Jun. 3, 2021, Innovation Pharma announced that it had achieved full patient enrollment in its randomized, double-blind,…
-
Moderna announced agreement to supply the Republic of Botswana with COVID-19 vaccine
On Jun. 3, 2021, Moder’s vaccine against COVID-19, to support the government’s ongoing efforts to secure access to…
-
Lonza and Moderna announced collaboration for drug substance manufacturing of COVID-19 Vaccine in the Netherlands
On Jun. 2, 2021, Lonza announced the expansion of its collaboration with Moderna. The expanded collaboration extended the…
-
Relief Therapeutics reported that NRx Pharma, had submitted an application for EUA for Aviptadil to the U.S. FDA
On Jun. 2, 2021, NRx Pharmaceuticals announced it had filed an application with U.S. Food and Drug Administration…
-
UNICEF and Moderna announced long term agreement to supply vaccine on behalf of the COVAX facility
On Jun. 2, 2021, UNICEF announced it had signed a long-term agreement with Moderna for the supply of COVID-19 vaccine on behalf of the…
-
Vaxxas and collaborators revealed potential of Vaxxas’ high-density microarray patch to deliver SARS-CoV-2 vaccine
On Jun. 2, 2021, Vaxxas announced that research demonstrated the potential of Vaxxas’ novel high-density microarray patch (HD-MAP)…
-
NIH launched clinical trial of universal influenza vaccine candidate
On Jun. 1, 2021, the National Institutes of Health (NIH) announced the first-in-human, Phase 1 trial assessing the…
-
Scientists discovered a new genetic form of ALS in children
On Jun. 1, 2021, in a study of 11 medical-mystery patients, an international team of researchers led by…
-
Sanofi and Parkinson’s Foundation collaborated to advance availability of free genetic testing and counseling for people with Parkinson’s disease
On Jun. 1, 2021, Sanofi announced that Vaxelis (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus…
-
WHO validated Sinovac COVID-19 vaccine for emergency use
On Jun. 1, 2021, World Health Organization (WHO) validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries,…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine | WHO
WHO $50 billion health, trade and finance roadmap to end the pandemic and secure a global recovery
On Jun. 1, 2021, the heads of the world’s predominant global financing, health and trade agencies united to…
-
NIH clinical trial evaluating mixed COVID-19 vaccine schedules began
On Jun. 1, 2021, the National Institutes of Health (NIH) announced that it had started a Phase 1/2…
-
AquaBounty received approval for the sale of GE Atlantic Salmon in Brazil
On Jun. 1, 2021, AquaBounty Technologies announced the successful completion of the first commercial scale harvest of its…
-
Moderna announced rolling submission of Biologics License Application with FDA for COVID-19 vaccine
On Jun. 1, 2021, Moderna announced that it had initiated the rolling submission process with the U.S. Food…
-
CytoDyn received first order from Chiral Pharma for use of Leronlimab for COVID-19 patients in the Philippines
On Jun. 1, 2021, CytoDyn announced that Chiral Pharma in the Philippines placed its first purchase order for…
-
HHS launched first venture capital partnership to develop transformative technologies to combat future pandemics
On Jun. 1, 2021, the U.S. Department of Health and Human Services (HHS) unveiled a new type of…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics
FDA approved LUMAKRAS for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer
On May 28, 2021, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved LUMAKRAS (sotorasib)…
-
Pfizer and BioNTech received first authorization in European Union for COVID-19 vaccine in adolescents
On May 28, 2021, Pfizer and BioNTech announced that the Conditional Marketing Authorization for COMIRNATY in the European…
-
Novartis and Molecular Partners announced start of EMPATHY clinical trial for ensovibep for treatment of COVID-19
On May 27, 2021, Novartis and Molecular Partners announced the start of the clinical trial EMPATHY, a Phase…
-
Patient enrollment reached 90 percent in Innovation Pharma’s phase 2 clinical trial of brilacidin for COVID-19
On May 27, 2021, Innovation Pharma announced that patient enrollment in the Company’s 120-patient, Phase 2 clinical trial…
-
Seattle Children’s researchers discovered that functional COVID-19 antibodies are lost quickly after mild cases
On May 27, 2021, Seattle Children’s researchers published a study that uncovered a deeper understanding of why people…
-
University of Oxford launched Pandemic Sciences Centre
On May 27, 2021, the University of Oxford has today announced the launch of a new centre of…
-
Biotechnology | Diagnostics | FDA | Infectious Disease | NIH | Therapeutics
NIAID scientists found that Salmonella use intestinal epithelial cells to colonize the gut
On May 26, 2021, National Institutes of Health (NIH) scientists reported that the immune system’s attempt to eliminate…
-
Altimmune demonstrated strong neutralization of South African variant in preclinical study of intranasal AdCOVID
On May 26, 2021, Altimmune announced new results from a preclinical study demonstrating the ability of its AdCOVID…
-
Henry Schein awarded Strategic National Stockpile contract for PPE storage and distribution
On May 26, 2021, Henry Schein announced the Company was awarded a $53.4 million contract from the U.S….
-
GSK and Vir Biotech announced sotrovimab (VIR-7831) received EUA from the US FDA for treatment of mild-to-moderate COVID-19 in high-risk adults and paediatric patients
On May 26, 2021, GlaxoSmithKline and Vir Biotechnology announced the U.S. Food and Drug Administration (FDA) granted an…
-
China facing serious experimental monkey shortage during the COVID-19 lockdown
On May 26, 2021, the National Center for Biotechnology Information announced a report that aimed to analyze the…
-
ImmunityBio expanded South African trials of T-cell-based COVID-19 vaccine candidate as ‘Universal Boost’ in vaccinated subjects
On May 25, 2021, ImmunityBio announced two South African studies to examine the potential for using its hAd5…
-
Moderna announced TeenCOVE study of COVID-19 vaccine in adolescents met primary endpoint
On May 25, 2021, Moderna announced that the Phase 2/3 study of its COVID-19 vaccine (mRNA-1273) in adolescents…
